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performance and carcass
characteristics of long-fed
steer and heifer calves1,2
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De Soto, KS 66018; ‡Cattlemen’s Nutrition Services LLC, Lincoln, NE 68506; §Bos Terra LP.,
Hobson, MT 59452; and #Innovative Livestock Services Inc., Great Bend, KS 67530

ABSTRACT
Three experiments evaluated initial
implant strategies for finishing cattle. In
Exp. 1, heifers (n = 1,405; initial BW
= 282 kg) were given (1) Revalor-IH
followed by Revalor-200 (REV-IH/200),
(2) Revalor-H followed by Revalor-200
(REV-H/200), or (3) Revalor-200 followed by Revalor-200 (REV-200/200).
Intake, ADG, and G:F were not affected
(P ≥ 0.14) by implant strategies, nor
were HCW and LM area (P ≥ 0.16).
Percent USDA Choice was greater (P
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< 0.01) for Rev-IH/200 compared with
Rev-H/200 and Rev-200/200. Experiment 2 used steers (n = 1,858; initial
BW = 250 kg) given (1) Revalor-IS
reimplanted with Revalor-200 (RevIS/200), (2) Revalor-XS followed by
Revalor-IS (Rev-XS/IS), (3) Revalor-XS
followed by Revalor-S (Rev-XS/S), or
(4) Revalor-XS followed by Revalor-200
(Rev-XS/200). Implanting strategies
did not affect (P ≥ 0.32) DMI or G:F.
Carcass traits were not different (P ≥
0.18) among treatments, except steers
implanted with Rev-XS/200 had greater
(P < 0.01) LM area. In Exp. 3, steers
(n = 1,408; initial BW = 305 kg) were
given (1) Rev-IS/200, (2) Rev-200/200,
or (3) Rev-XS/200. Gain and G:F
did not differ (P ≥ 0.36) among the
3 implant strategies, nor did HCW or
marbling score (P ≥ 0.15). Steers given
Rev-XS/200 had greater (P < 0.01) LM
area and decreased (P ≤ 0.05) 12th-rib
fat and YG compared with Rev-200/200

and Rev-IS/200. Using Rev-200/200 and
Rev-XS/200 increased (P = 0.03) USDA
Select compared with Rev-IS/200. Using
greater-initial-dose implant strategies
may not affect ADG or G:F but appears
to increase leanness.
Key words: carcass characteristic,
finishing performance, implant strategy

INTRODUCTION
Growth-promoting implants provide
considerable improvements in production efficiencies to the beef cattle
industry (Folmer et al., 2009; Nichols
et al., 2014). Despite these improvements, the majority of implants only
last 60 to 120 d, depending on the
dose, before they are no longer effective. Because many cattle require
more than 120 d to reach slaughter
weight, reimplanting becomes an
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important management strategy to
improve animal efficiency (Preston,
1999). For instance, cattle implanted
with 2 consecutive combination implants containing trenbolone acetate
(TBA) and estradiol-17β (E2) have
demonstrated a 20.0% increase in
ADG and a 13.5% improvement in
BW gain efficiency compared with
nonimplanted cattle (Duckett and
Pratt, 2014). Implanting strategies
use different combinations of implants
based on cattle, age, weight, sex,
production goals, and estimated days
on feed to target gain efficiency, lean
meat yield, and carcass quality (Mader, 1997; Reinhardt, 2007; Johnson et
al., 2013). With demand for increased
gain efficiency and lean meat yield,
usage of greater-dose implants has
increased; however, data are limited
on the use of these implant combinations in long-fed calves over 170 d.
Therefore, the objectives of these
experiments were to compare feedlot
and carcass performance of long-fed
heifers and steers receiving different
aggressive initial implant strategies in
commercial feedlots.

MATERIALS AND METHODS
The following experiments were
conducted in collaborations between
Merck Animal Health (De Soto,
KS), Cattlemen’s Nutrition Service
LLC (Lincoln, NE), Bos Terra LP.
(Hobson, MT), Innovative Livestock
Services Inc. (Great Bend, KS), and
the University of Nebraska–Lincoln.
Research was conducted at commercial facilities and followed the
guidelines stated in the Guide for the
Care and Use of Agricultural Animals
in Agricultural Research and Teaching
(FASS, 2010).

Exp. 1
Animals and Treatments. British and British × Continental heifer
calves (n = 1,405; 282 ± 3 kg of
initial BW) were fed at a commercial
feedyard in central Nebraska from
May 2011 to November 2011 (days
on feed across blocks averaged 173
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d). Heifers were sourced from several sale barns located in Oklahoma.
Treatments were (1) Revalor-IH (80
mg of TBA + 8 mg of E2; Merck
Animal Health, Madison, NJ) at
initial processing followed 89 d later
by Revalor-200 (200 mg of TBA +
20 mg of E2; Merck Animal Health;
REV-IH/200); (2) Revalor-H (140
mg of TBA + 14 mg of E2; Merck
Animal Health) at initial processing
followed 89 d later by Revalor-200
(REV-H/200); or (3) Revalor-200 at
initial processing followed 89 d later
by Revalor-200 (REV-200/200).
Heifers were allotted randomly to
pen by arrival block (n = 6) by sorting every 2 heifers into 1 of 3 pens
before initial processing. Implant
treatments were assigned randomly to
pen (n = 1) within a block, for a total
of 18 pens. After heifers were randomized into their respective pens, each
pen was group weighed on a platform
scale before processing to establish
pen initial BW. Only products approved by the USDA and United
States Food and Drug Administration
were administered according to label
directions during this study. At processing, heifers received a combination
vaccine (Bovi-Shield Gold, Zoetis Inc.,
Florham Park, NJ) against infectious
bovine rhinotracheitis (IBR) virus,
bovine virus diarrhea (BVD) virus
types 1 and 2, parainfluenza 3 (PI3)
virus, and bovine respiratory syncytial virus (BRSV). Additionally,
heifers received an oral dose of 10%
fenbendazole solution (Safe-Guard,
Merck Animal Health) for treatment
of internal parasites, an injection of
1% moxidectin (Cydectin, Boehringer
Ingelheim/Vetmedica St. Joseph, MO)
for treatment of external parasites,
and an implant based on the specified treatment assigned. At reimplant
(d 90), all pens within a block were
brought to the processing facility,
reimplanted with Revalor-200, and
pen weighed.
Cattle were housed in 18 open lots
with earthen mounds. Each animal
had ad libitum access to clean water
and their respective diet. Cattle were
started on feed with a 56% concen-

trate, 44% roughage diet. Over a 26-d
period, 2 intermediate diets were used
to transition cattle to a finishing diet.
The finishing diet consisted of 49.1%
dry-rolled corn, 40% wet distillers
grains plus solubles, 6.5% mixed hay,
and 4.4% supplement (DM basis).
The supplement was formulated to
provide 300 mg per heifer daily of
monensin (Rumensin; Elanco Animal
Health, Indianapolis, IN), 90 mg per
heifer daily of tylosin phosphate (Tylan; Elanco Animal Health), and 0.45
mg per heifer daily of melengestrol
acetate (Heifermax; Elanco Animal
Health). All heifers were fed zilpaterol
hydrochloride at 8.33 mg/kg of DM
(Zilmax; Merck Animal Health) for 20
d followed by a 3-d withdrawal before
slaughter. Heifers were fed twice daily
at approximately 0700 and 1300 h in
concrete, fence-line feedbunks, with
feedbunks visually evaluated each
morning. Feedbunks were managed to
allow trace amounts of feed to remain
in the bunk before feed delivery. Diet
samples were obtained monthly from
feedbunks and composited for nutrient analysis (Servi-Tech Laboratories,
Hastings, NE). Diets provided protein
and minerals to meet or exceed NRC
(1996) requirements and contained
greater than 1.45 Mcal/kg of NEg.
Carcass Evaluation. Slaughter
date was determined based on reimplant weight. Prior to shipping for
slaughter, heifers from each pen were
group weighed on platform scales and
shrunk 4% to calculate DP and final
live BW. After weighing, heifers were
immediately loaded onto trucks and
transported 201 km to a commercial
abattoir (JBS, Grand Island, NE).
Carcass-adjusted final BW was calculated as average HCW divided by
the average DP of 65.85% across all
animals. Carcass data were collected
by personnel from West Texas A&M
University (Canyon, TX). Individual
HCW were collected at slaughter,
and following a 24-h chill, 12th-rib fat
thickness, LM area, DP, KPH, marbling scores, percent USDA QG, and
percent USDA YG were collected for
each pen. Yield grade was calculated
using the equation of YG, where YG
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= 2.50 + (6.35 × 12th-rib fat depth,
cm) − (2.06 × LM area, cm2) + (0.2
× KPH, %) + (0.0017 × HCW, kg)
(Boggs and Merkel, 1993).

Exp. 2
Animals and Treatments.
Crossbred steer calves (n = 1,858;
initial BW 250 ± 19 kg) sourced from
auction markets or ranches between
October 11 and November 11, 2011,
were fed at a commercial feedyard in
central Montana (days on feed ranged
from 196 to 238; average = 215).
Treatments were (1) Revalor-IS (80
mg of TBA and 16 mg of E2; Merck
Animal Health) implant at initial
processing followed by Revalor-200
implant on d 120 (Rev-IS/200), (2)
Revalor-XS (200 mg of TBA and 40
mg of E2; Merck Animal Health) implant at initial processing followed by
Revalor-IS implant on d 140 (RevXS/IS), (3) Revalor-XS implant at
initial processing followed by RevalorS (120 mg of TBA and 24 mg of E2;
Merck Animal Health) implant on d
140 (Rev-XS/S), or (4) Revalor-XS
implant at initial processing followed
by Revalor-200 implant on d 140
(Rev-XS/200).
Upon arrival steers were blocked
by BW into heavy (>272 kg) or light
(<272 kg) blocks. Once a replication
was full (approximately 200 steers),
cattle were assigned randomly at
processing to treatment and pen (n
= 32 total pens; 49 to 86 steers per
pen). Altogether there were 8 pens
per treatment, with 5 replications of
treatment in the heavy block and 3
replications of treatment in the light
block. At processing, steers were
individually weighed and received
an individual electronic and visual
feedlot identification tag; prophylactic administration based on label
recommendations of tulathromycin
(Draxxin; Zoetis); a vaccine consisting of IBR virus, BVD virus (types I
and II), PI3 virus, BRSV, Mannheimia
haemolytica and Pasteurella multocida
(Vista Once; Merck Animal Health);
a vaccine consisting of Clostridium
chauvoei, Clostridium septicum, Clostridium novyi, Clostridium sordellii,

Clostridium perfringens types C&D
(enterotoxemia), and Haemophilus
somnus (Vision 7 Somnus; Merck
Animal Health). Additionally, they
received an oral dose of 10% fenbendazole solution (Safe-Guard; Merck
Animal Health) for control of internal
parasites; an injection of ivermectin
(Ivomec; Merial, Duluth, GA) for control of internal and external parasites;
and an implant based on the specified
treatment assignment. At time of reimplant, steers were given a terminal
implant based on treatment protocol
and also received a booster vaccine
consisting of IBR, BVD (types I and
II), PI3, and BRSV (Vista 5; Merck
Animal Health) and an injection of
ivermectin. All USDA and United
States Food and Drug Administration approved products were used
according to label directions. Within
replication, steers in Rev-IS/200
pens were reimplanted at 120 d on
feed, and Rev-XS/IS, Rev-XS/S, and
RevXS/200 pens were reimplanted at
140 d on feed. Differences in reimplant date differed because the recommended length of Rev-IS lasts up to
120 d, whereas Rev-XS can last up to
220 d.
Following initial processing, steers
were group weighed by pen on a
platform scale to establish pen initial BW to be used in performance
calculations. Steers were housed in
open feedlot pens and had ad libitum
access to feed and water. Cattle were
adapted to a common finishing diet
over a 21-d period, and cattle were
fed once daily at approximately 0700
h. The finishing diet contained 61.24%
wheat or barley, 20% corn dry distillers grains plus solubles, 7.5% mixed
wheat and barley silage, 7.5% alfalfa
hay, and 3.76% supplement (DM
basis). Diets were common across all
pens over the feeding period, and any
grain source changes were made to
all treatments simultaneously. The
supplement was formulated to provide
monensin (Rumensin; Elanco Animal
Health) at 300 mg per steer daily and
tylosin phosphate (Tylan-40; Elanco
Animal Health) at 90 mg per steer
daily on a DM basis. Steers were
fed zilpaterol hydrochloride (Zilmax;

Merck Animal Health) at 8.33 mg/
kg of DM for 20 d followed by a 3-d
withdrawal before slaughter. Diet
samples were obtained monthly from
feedbunks and composited for nutrient analysis (Dairy One Labs, Ithaca,
NY). Diets provided protein and minerals to meet or exceed NRC (1996)
requirements and contained greater
than 1.38 Mcal/kg of NEg.
Carcass Evaluation. Slaughter
date was determined based on reimplant weight. Steers were weighed by
pen on platform scales and shrunk
4% before shipping to determine final
shrunk BW. After weighing, steers
were immediately loaded on trucks
and transported approximately 1,036
km to a commercial abattoir (JBS,
Greeley, CO) for slaughter. Carcassadjusted final BW was calculated as
HCW divided by a fixed DP of 61.0%
across all steers. Carcass measurements were reported by the abattoir
based on USDA grades. Individual
carcass measurements were collected
using the procedures described in
Exp. 1.

Exp. 3
Animals and Treatments. Experiment 3 was conducted at a commercial feedlot in central Nebraska
from February 2, 2013, to October 15,
2013 (days on feed ranged from 181
to 209; average = 195 d). Cross-bred
steers (n = 1,408; initial BW = 305
± 10 kg) from ranches and auction
barns in Nebraska, Nevada, and Utah
were used for the trial. Treatments
were (1) Revalor-IS given on d 1 followed by Revalor-200 on d 115 (RevIS/200); (2) Revalor-200 given on d
1 followed by Revalor-200 on d 115
(Rev-200/200); or (3) Revalor-XS
given on d 1 followed by Revalor-200
on d 115 (Rev-XS/200).
Steers were blocked (n = 3) by
arrival date and projected slaughter
date based on initial weight. Prior to
processing, steers were allocated into
1 of 3 sort pens by sorting every 2
steers in the alley. Sort pens were assigned randomly to 1 of 3 treatments
(n = 18; 68 to 95 steers per pen; 6
pens per treatment).
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During initial processing, cattle
were individually weighed; vaccinated
against IBR, BVD (types I and II),
PI3, and BRSV (Vista 3 SQ; Merck
Animal Health); given an oral dose
of 10% fenbendazole solution (SafeGuard, Merck Animal Health) for
treatment of internal parasites and an
injection of 1% moxidectin (Cydectin,
Boehringer Ingelheim/Vetmedica)
for treatment of external parasites;
and individually identified. Following
initial processing, steers were group
weighed by pen on a platform scale to
establish pen initial BW to be used
in performance calculations. At time
of reimplantation, all cattle within
a replication were brought to the
processing facility based on a random
assignment of processing order and
reimplanted with Revalor-200.
Steers were adapted to a common
finishing diet over a 23-d transition
period consisting of 3 adaptation diets. The finishing diets were the same
for each treatment but varied across
time because of availability of ingredients. Weighted averages were 49.9%
dry-rolled corn (range 41.1–54.6%),
19.2% ADM-Synergy (ADM, Columbus, NE; range 0–28%), and 19.6%
wet distillers grains with solubles
(range 12–35%). The finishing diet
also contained 5% liquid supplement
(range 4.1–5.2%), 3.9% mixed hay
(range 3.5–4.0%), and 2.4% corn
silage (range 0–3%). The supplement
was formulated to provide 360 mg per
steer daily of monensin (Rumensin;
Elanco Animal Health) and 90 mg per
steer daily of tylosin phosphate (Tylan; Elanco Animal Health). Because
of timing of the trial, at the end of
the feeding period, 3 replications were
fed zilpaterol hydrochloride (Zilmax;
Merck Animal Health) and 3 replications were fed ractopamine hydrochloride (Optaflexx; Elanco Animal
Health). Zilpaterol was fed at a rate
of 8.33 mg/kg of DM for 20 d followed
by a 3-d withdrawal before slaughter.
Ractopamine was fed at a rate of 300
mg per steer daily for the last 28 d
of the feeding period. Feeding of a
β-agonist was equal across treatments
and within a replication as all cattle
were fed either Zilmax or Optaflexx
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and therefore not included in the
statistical model. Diet samples were
obtained monthly from the feedbunks
and composited for nutrient analysis
(Servi-Tech Laboratories). Diets provided protein and minerals to meet or
exceed NRC (1996) requirements and
contained greater than 1.45 Mcal/kg
of NEg while on the finishing diet.
Carcass Evaluation. Steers were
weighed by pen on platform scales
and shrunk 4% before shipping to
determine final shrunk BW. After
weighing, cattle were immediately
loaded on trucks and transported approximately 189 km to a commercial
abattoir (JBS, Grand Island, NE) for
slaughter. Carcass-adjusted final BW
was calculated as HCW divided by
the DP of 64.5% across all animals.
Carcass data were collected by personnel from West Texas A&M University. Individual carcass measurements
were the same as described in Exp. 1.

Deads-In and Deads-Out
Calculations and Statistical
Analysis
Deads-In Calculations. Calculations were made for initial weight
by taking the initial pen average (no
shrink) divided by the total number of cattle at the start of the trial
(Exp. 1, 2, and 3). Final live BW was
calculated using the total weight of
pen at shipping (shrunk 4%) plus the
weight of cattle sold early because of
chronic sickness or injury, divided by
the number of animals that started
the trial (Exp. 1, 2, and 3). Deads-in
ADG was calculated from the total
kilograms gained (total final weight
plus weight of cattle sold early minus
total initial weight) divided by total
number of animal days (Exp. 1, 2,
and 3). Total DMI was calculated by
dividing total feed delivered to the
pen by the total number of animal
days (Exp. 1, 2, and 3). Gain-to-feed
ratio was calculated using the deadsin ADG divided by DMI (Exp. 1, 2,
and 3).
Deads-Out Calculations. Deadsout initial weight was calculated the
same as deads-in (Exp. 1 and 2).
Deads-out initial BW was calculated

by subtracting individual weight of
dead steers or removals from the total
initial pen weight, divided by the
number of animals slaughtered (Exp.
3). Final live BW was calculated using the total weight of cattle at shipping (shrunk 4%) divided by the total
number of cattle shipped excluding
deads and cattle sold early (Exp. 1, 2,
and 3). Deads-out ADG was determined by dividing the total weight
gain (average final weight − average starting weight) by days on feed
(Exp. 1, 2, and 3). Deads-out DMI
was the same as deads-in, and G:F
was calculated using deads-out ADG
divided by DMI (Exp. 1, 2, and 3).
Carcass-adjusted ADG and G:F were
calculated using the same calculations
as deads-out ADG and G:F (Exp. 1,
2, and 3).
Statistical Analysis. Live performance and carcass data were analyzed as a randomized complete block
design using the Glimmix procedure
of SAS (9.2, SAS Institute Inc., Cary,
NC). Pen was the experimental unit
and the model included the fixed effect of treatment, with block as a random effect (Exp. 1 and 3). The model
included replication as a random effect with experimental treatment and
weight block as fixed effects (Exp. 2).
Treatment averages were calculated
using the LSMEANS option of SAS.
Treatment differences were significant
at an α value equal to or less than
0.05. Frequency data were analyzed
using the Glimmix procedure of SAS.
The model specified a logistic link
function for the binary response, with
the number of animals slaughtered
identified in the denominator. The
means and SE of the proportions for
the frequency data were determined
using the ILINK option. Treatment
differences were significant at an α
value equal to or less than 0.05.

RESULTS AND DISCUSSION
Exp. 1—Performance
Deads-out live and carcass-adjusted
BW, DMI, and ADG were not different (P ≥ 0.14) between the 3 implant
strategies (Table 1). Carcass-adjusted

57

Initial implant strategies for feedlot cattle

Table 1. Effects of increased initial implant dose on growth performance and carcass characteristics of heifer
calves fed for 173 d (Exp. 1)
Treatment1
Item
No. of heifers (pens)
Initial BW,2 kg
DMI,3 kg/d
Deads-in performance4
Live performance
   Final BW, kg
   ADG, kg
  G:F
Deads-out performance5
Live performance
   Final BW, kg
   ADG, kg
  G:F
Carcass-adjusted performance6
   Final BW, kg
   ADG, kg
  G:F
HCW, kg
DP, %
12th-rib fat thickness, cm
LM area, cm2
Marbling score7
Calculated YG
USDA QG,8 %
Prime
Choice
Select
≤Standard
USDA YG,8 %
1
2
3
4
5

Rev-IH/200

Rev-H/200

Rev-200/200

SE

P-value

473 (6)
282
9.70

466 (6)
281
9.57

466 (6)
283
9.69

—
3.1
0.05

—
0.74
0.14

529
1.50
0.155

542
1.56
0.163

532
1.51
0.156

12.3
0.06
0.006

0.35
0.44
0.27

566
1.65
0.170

565
1.65
0.172

568
1.65
0.171

3.9
0.02
0.001

0.73
0.95
0.28

568
1.65
0.171
374
65.98
1.52
98.87
428a
2.61

564
1.64
0.171
371
65.64
1.44
99.98
401b
2.46

568
1.66
0.171
374
65.93
1.53
99.88
400b
2.58

3.9
0.15
0.001
2.6
0.10
0.06
0.94
4.9
0.09

0.16
0.33
0.94
0.16
0.09
0.08
0.29
0.01
0.06

0.69
60.55a
32.11a
6.65a

0.45
49.10b
43.89b
6.56a

0.92
42.53b
43.45b
13.10b

0.46
2.38
2.38
1.62

0.72
<0.01
<0.01
0.01

11.81a
38.43
39.12a
10.19
0.46

17.05b
36.36
37.27a
8.18
1.14

18.14b
42.33
27.21b
10.93
1.40

1.86
2.34
2.35
1.51
0.57

0.05
0.22
<0.01
0.39
0.42

Means within a row with different superscripts differ (P < 0.05).
Rev-IH/200 = Revalor-IH at processing and Revalor-200 at reimplant on d 89; Rev-H/200 = Revalor-H at processing and
Revalor-200 at reimplant on d 89; Rev-200/200 = Revalor-200 at processing and Revalor-200 at reimplant on d 89. Revalor-IH,
Revalor-H, Revalor-200, Merck Animal Health (De Soto, KS).
2
Initial BW: total pen weight of cattle with no shrink divided by total number of starting heifers (deads-in and deads-out).
3
DMI: calculated from total kilograms delivered to the pen divided by total number of animal days.
4
Deads-in performance: ADG was calculated from total kilograms gained (total final weight plus removed weight after subtracting total
starting weight) divided by total number of animal days. G:F was calculated from deads-in ADG divided by pen DMI.
5
Deads-out performance: live ADG was calculated from total kilograms gained (average final weight subtracting average starting
weight) divided by average days on feed. Live G:F was calculated from deads-out ADG divided by pen DMI. Carcass-adjusted
performance ADG was calculated the same as live performance using carcass-adjusted final BW.
6
Carcass-adjusted final BW was calculated as average HCW divided by the average DP of 65.85% across all animals.
7
Marbling score: 400 = small00, 500 = modest00.
8
The numbers represent by treatment the proportion of carcasses within each QG and YG category.
a,b

1

58
G:F was not different (P = 0.94) and
was 0.171 across all 3 implant treatments. Similarly, there were no differences (P ≥ 0.27) in deads-in ADG
and G:F. Folmer et al. (2009) reported that when comparing similar initial
implant dosages, there were no differences in DMI and live and carcassadjusted final BW. There were differences in live and carcass-adjusted G:F
in heifers fed for 177 d (Folmer et al.,
2009). Guiroy et al. (2002) reported
no differences in ADG and G:F for
heifers implanted with either Rev-IH
or Rev-H as an initial implant and
Rev-H as a common terminal implant
and fed for 189 d.
Carcass characteristics were not
different (P ≥ 0.16) among the 3
strategies for HCW and LM area.
The Rev-H/200 implant combination did have a numerically lesser (P
≥ 0.08) DP and 12th-rib fat thickness, which could have contributed
to a numerically lesser (P = 0.06)
calculated YG compared with RevIH/200 and Rev-200/200. Similar to
this study, Schneider et al. (2007)
reported no differences in 12th-rib
fat thickness, HCW, LM area, and
YG between carcasses of heifers that
received similar implant protocols.
Heifers that received Rev-IH/200
had significantly greater (P = 0.01)
marbling scores compared with the
Rev-H/200 and Rev-200/200 treatments. Quality grade distribution
reflected this difference in marbling
score with the Rev-IH/200 treatment having a greater percentage
(P < 0.01) of carcasses that graded
Choice and a lesser percentage (P <
0.01) of carcasses that graded Select
compared with the Rev-H/200 and
Rev-200/200 treatments. Additionally, the Rev-IH/200 and Rev-H/200
treatments had a lesser percentage (P
= 0.01) of carcasses that graded less
than or equal to Standard compared
with the Rev-200/200 treatment.
Schneider et al. (2007) and Folmer et
al. (2009) reported no differences in
marbling score; additionally, Folmer
et al. (2009) reported no difference in
the total number of carcasses grading
Choice but a greater percentage of
carcasses graded in the upper two-
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thirds of Choice when a milder RevIH/200 implant protocol was used.
The percentage of YG 1 carcasses
was greater (P = 0.05) for RevH/200 and Rev-200/200 than for
Rev-IH/200. The percentage of YG 3
carcasses was greater (P < 0.01) for
Rev-IH/200 and Rev-H/200 compared with Rev-200/200. In contrast
to the current study, Folmer et al.
(2009) reported no differences in the
YG distribution. Consistent with our
observations Hutcheson et al. (2002)
reported no differences in gain during
the finishing period but a decrease
in marbling score as implant dosage
was increased. Increasing the dosage
of initial implant seems to have little
effect on animal gains and feed efficiency; however, the increased dosage
could have negative effects on carcass
fatness as evidenced by decreased
yield and QG. Hutcheson et al. (2002)
reported no differences in gain during
the finishing period but a decrease in
marbling score as implant dosage was
increased.

Exp. 2—Performance
While previous studies have used
Rev-XS as a single implant strategy
for steers fed for 131 to 243 d on
feed (Parr et al., 2011; Nichols et al.,
2014), there is little information available on using Rev-XS in combination
with other implants to maximize
production efficiency.
Cattle from different implanting
strategies did not differ (P ≥ 0.11)
in live or carcass-adjusted final BW;
however, cattle that received RevalorXS as an initial implant numerically
had heavier live and carcass-adjusted
final BW (Table 2). Intake was not
different (P = 0.38) across implant
strategy. Although not statistically different (P ≥ 0.13), steers
that received Rev-XS/IS, Rev-XS/S,
and Rev-XS/200 had numerically
greater deads-in and deads-out live or
carcass-adjusted ADG compared with
Rev-IS/200. Efficiency of gain was not
different (P ≥ 0.32) among implant
strategy on a live or carcass-adjusted
basis. Parr et al. (2011) reported no
differences in live and carcass-adjust-

ed final BW, DMI, ADG, and G:F for
cattle implanted with Rev-IS followed
by Rev-S at reimplant compared
with a single implant of Rev-XS at d
131, 174, and 243 on feed. Similarly,
Nichols et al. (2014) reported no differences in feedlot gain and efficiency
after 157 d on feed when cattle were
implanted with Rev-IS followed by
Rev-S at reimplant compared with a
single Rev-XS. Parr et al. (2011) reported an increase in carcass-adjusted
final BW and ADG when using a
single Rev-XS implant for 197 d compared with a Rev-IS/S implant program and suggested that this could
be due to decreased concentrations of
TBA and E2 before reimplanting (d
90 to 103), which caused a decrease
in overall gain. Samber et al. (1996)
evaluated different implant strategies
using multiple implants with similar
overall concentrations of TBA and
E2 as those used in the current study,
noting no differences in final BW,
DMI, ADG, and G:F between the
treatments.
In Exp. 2, HCW, DP, 12th-rib fat
thickness, and marbling scores were
not different (P ≥ 0.18) among implant treatments. Nichols et al. (2014)
reported no differences in HCW,
12th-rib fat thickness, or marbling
score when comparing Rev-XS with
Rev-IS/S. Similarly, Parr et al. (2011)
reported no differences in HCW, DP,
and 12th-rib fat thickness between
implant programs in cattle fed for
174 or 243 d. Contrary to the current
study, Samber et al. (1996) reported
that cattle implanted 3 times with
Rev-S compared with 2 times with
Rev-S had less 12th-rib fat thickness.
Longissimus muscle area was largest
(P < 0.01) for Rev-XS/200 implant
programs, with Rev-XS/IS and RevXS/S treatments being intermediate
and Rev-IS/200 having the smallest
LM area. Samber et al. (1996) also
reported that increasing the amount
of TBA and E2 used in the implant
program increased LM area but had
no effect on HCW or DP.
In Exp. 2, QG distributions were
not different (P ≥ 0.19) by implant
treatment. No significant differences
(P ≥ 0.07) were observed between
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Table 2. Effects of increased implant dose combinations on growth performance and carcass characteristics of
steer calves fed for 216 d (Exp. 2)
Treatment1
Item
No. of steers (pens)
Initial BW,2 kg
DMI,3 kg/d
Deads-in performance4
Live performance
   Final BW, kg
   ADG, kg/d
  G:F
Deads-out performance5
Live performance
   Final BW, kg
   ADG, kg/d
  G:F
Carcass-adjusted performance6
   Final BW, kg
   ADG, kg/d
  G:F
HCW,7 kg
DP, %
12th-rib fat thickness, cm
LM area, cm2
Marbling score8
Calculated YG
USDA QG,9 %
Prime
Premium Choice
Low Choice
Select
≤Standard
Dark cutter
USDA YG,9 %
1
2
3
4 and 5

Rev-IS/200

Rev-XS/IS

Rev-XS/S

Rev-XS/200

SE

P-value

463 (8)
255
10.71

467 (8)
257
10.88

465 (8)
257
10.97

463 (8)
256
10.83

—
2.9
0.14

—
0.60
0.38

584
1.56
0.146

602
1.63
0.150

592
1.59
0.145

603
1.63
0.151

9.9
0.04
0.004

0.11
0.13
0.32

615
1.60
0.156

624
1.70
0.156

621
1.68
0.153

624
1.70
0.157

8.0
0.03
0.003

0.11
0.13
0.46

625
1.72
0.160
381
62.28
1.23
88.75c
421
2.90

636
1.76
0.161
388
62.63
1.23
90.37b
417
2.88

632
1.73
0.158
386
62.52
1.23
90.16bc
407
2.87

636
1.76
0.163
388
62.63
1.18
91.96a
411
2.75

7.2
0.03
0.002
4.1
0.6
0.04
1.89
6.9
0.09

0.18
0.14
0.36
0.18
0.40
0.47
<0.01
0.27
0.06

0.96
14.94
41.20
39.52
2.17
1.21

1.38
11.24
43.58
39.22
3.44
1.15

1.18
10.85
37.74
44.81
3.77
1.65

1.62
10.65
40.28
43.75
3.00
0.69

0.61
1.75
2.42
2.42
0.93
0.62

0.86
0.20
0.39
0.25
0.58
0.66

10.36
45.54
37.35
6.75

10.78
48.17
35.55
5.51

13.68
43.63
36.56
6.13

12.96
52.78
30.32
3.94

1.67
2.45
2.38
1.23

0.38
0.07
0.16
0.34

Means within a row with different superscripts differ (P < 0.05).
Rev-IS/200 = Revalor-IS on d 0, Revalor-200 implant on d 120; Rev-XS/IS = Revalor-XS on d 0, Revalor-IS implant on d 140; RevXS/S = Revalor-XS on d 0, Revalor-S implant on d 140; Rev-XS/200 = Revalor-XS on d 0, Revalor-200 implant on d 140. Revalor-IS,
Revalor-S, Revalor-XS, Revalor-200, Merck Animal Health (De Soto, KS).
2
Initial BW: total pen weight of cattle with no shrink divided by total number of starting steers (deads-in and deads-out).
3
DMI: calculated from total kilograms delivered to the pen divided by total number of animal days.
4
Deads-in performance: ADG was calculated from total kilograms gained (total final weight plus removed weight after subtracting total
starting weight) divided by total number of animal days. G:F was calculated from deads-in ADG divided by pen DMI.
5
Deads-out performance: live ADG was calculated from total kilograms gained (average final weight subtracting average starting
weight) divided by average days on feed. Live G:F was calculated from deads-out ADG divided by pen DMI. Carcass-adjusted
performance ADG were calculated the same as live performance using carcass-adjusted final BW.
6
Carcass-adjusted final BW was calculated as HCW divided by the average DP of 61.0% across all steers.
7
One replication was slaughtered early and no data were collected, so carcass characteristics were analyzed with only 7 replications.
8
Marbling score: 400 = small00, 500 = modest00.
9
The numbers represent by treatment the proportion of carcasses within each QG and YG category.
a–c
1
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Table 3. Effects of increased implant dose combinations on growth performance and carcass characteristics of
steer calves fed for 195 d (Exp. 3)
Treatment1
Item
No. of steers (pens)
Initial BW,2 kg
DMI,3 kg/d
Deads-in performance4
Live performance
   Final BW, kg
   ADG, kg/d
  G:F
Deads-out performance5
Live performance
   Final BW, kg
   ADG, kg/d
  G:F
Carcass adjusted performance6
   Final BW, kg
   ADG, kg/d
  G:F
HCW, kg
DP, %
LM area, cm2
12th-rib fat thickness, cm
Marbling score7
Calculated YG
USDA QG,8 %
Prime
Premium Choice
Low Choice
≤Select
USDA YG,8 %
1
2
3
4
5

Rev-IS/200

Rev-200/200

Rev-XS/200

SE

P-value

473 (6)
307
11.05

471 (6)
305
11.12

464 (6)
306
10.98

—
4.6
0.16

—
0.81
0.58

633
1.72
0.155

633
1.72
0.156

632
1.71
0.156

7.0
0.06
0.002

0.99
0.95
0.96

670
1.86
0.168

671
1.88
0.170

667
1.85
0.169

4.7
0.02
0.002

0.70
0.51
0.49

674
1.88
0.170
435
64.88
96.73a
1.78a
475
3.51a

672
1.88
0.170
434
64.67
97.86a
1.79a
457
3.44a

676
1.90
0.173
436
65.31
100.75b
1.67b
461
3.20b

6.6
0.02
0.003
4.3
0.4
0.66
0.07
13.3
0.10

0.64
0.68
0.36
0.64
0.11
<0.01
0.05
0.15
0.01

2.50
27.73
50.45
19.32b

1.13
23.13
48.30
27.44a

1.37
25.06
47.38
26.20a

0.74
2.13
2.38
2.13

0.28
0.32
0.65
0.03

3.91a
22.07
45.06
25.75a
3.22

5.91ab
25.45
40.68
23.41a
4.55

8.95b
29.59
44.27
15.83b
1.38

1.12
2.19
2.39
2.10
0.99

0.03
0.07
0.40
0.01
0.06

Means within a row with different superscripts differ (P < 0.05).
Rev-IS/200 = Revalor-IS at processing and Revalor-200 at reimplant on d 115; Rev-200/200 = Revalor-200 at processing and
Revalor-200 at reimplant on d 115; Rev-XS/200 = Revalor-XS at processing and Revalor-200 at reimplant on d 115. Revalor-IS,
Revalor-200, Revalor-XS, Merck Animal Health (De Soto, KS).
2
Initial BW: total pen weight of cattle with no shrink subtracting individual weights of dead or removed animals divided by the number
of remaining animals (deads-out).
3
DMI: calculated from total kilograms delivered to the pen divided by total number of animal days.
4
Deads-in performance: ADG was calculated from total kilograms gained (total final weight subtracting total starting weight with deads
and removed included) divided by total number of animal days. G:F was calculated from deads-in ADG divided by pen DMI.
5
Deads-out performance: live ADG was calculated from total kilograms gained (average final weight subtracting average starting
weight) divided by average days on feed. Live G:F was calculated from deads-out ADG divided by pen DMI. Carcass-adjusted
performance ADG were calculated the same as live performance using carcass-adjusted final BW.
6
Carcass-adjusted final BW was calculated as HCW divided by the DP of 64.5% across all animals.
7
Marbling score: 400 = small00, 500 = modest00.
8
The numbers represent by treatment the proportion of carcasses within each QG and YG category.
a,b
1
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Table 4. Health data for calf-fed heifers and steers implanted with different aggressive implant strategies
Treatment2
Item1
Exp. 1
Morbidity (total pulls),3 %
Mortalities,4 %
Removal,5 %
Exp. 2
Morbidity (total pulls),3 %
Mortalities,4 %
Removal,5 %
Exp. 3
Morbidity (total pulls),3 %
Mortalities,4 %
Removal,5 %

Rev-IH/200

Rev-H/200

Rev-200/200

SE

P-value

10.57b
3.59
2.96
Rev-IS/200

16.31a
1.29
2.58
Rev-XS/IS
Rev-XS/S

12.23ab
2.58
3.86
Rev-XS/200

1.71
0.86
0.89

0.05
0.12
0.53

12.53b
3.02
0.86
Rev-XS/200

1.89
1.07
0.43

0.02
0.26
0.63

14.01
1.51
3.66

1.67
0.57
0.97

0.60
0.81
0.75

15.98ab
5.62
0.00
Rev-IS/200
15.64
1.48
4.23

16.92ab
21.08a
3.64
4.30
0.21
0.86
Rev-200/200
13.38
1.06
4.67

The numbers represent by treatment the proportion of animals within each category treated for morbidity, mortalities, or removed.
Exp. 1: Rev-IH/200 = Revalor-IH at processing and Revalor-200 at reimplant on d 89; Rev-H/200 = Revalor-H at processing and
Revalor-200 at reimplant on d 89; Rev-200/200 = Revalor-200 at processing and Revalor-200 at reimplant on d 89. Exp. 2: RevIS/200 = Revalor-IS at initial processing followed by Revalor-200 implant on d 120; Rev-XS/IS = Revalor-XS at initial processing
followed by Revalor-IS implant on d 140; Rev-XS/S = Revalor-XS implant at initial processing followed by Revalor-S implant on d
140; Rev-XS/200 = Revalor-XS implant at initial processing followed by Revalor-200 implant on d 140. Exp. 3: Rev-IS/200 = RevalorIS at processing and Revalor-200 at reimplant on d 115; Rev-200/200 = Revalor-200 at processing and Revalor-200 at reimplant on
d 115; Rev-XS/200 = Revalor-XS at processing and Revalor-200 at reimplant on d 115. Revalor-IH, Revalor-H, Revalor-200, RevalorIS, Revalor-S, Revalor-XS, Merck Animal Health (De Soto, KS).
3
Morbidity = any animals treated for sickness during the trials.
4
Mortality = any animals that died from d 0 to the end of the trial.
5
Removal = any animals that were removed from the trial and sold early because of chronic sickness or injury.
1
2

treatments for any of the YG categories; however, the Rev-IS/200
and the Rev-XS/S numerically had a
lesser percentage of YG 2 carcasses,
which led to an increase in YG 3
carcasses compared with Rev-XS/IS
and Rev-XS/200. Parr et al. (2011)
and Nichols et al. (2014) noted differences in the percentage of Choice and
Select carcasses in cattle fed for 131,
157, and 243 d, with cattle receiving a single Rev-XS implant having
more Choice and less Select grading
carcasses compared with RevIS/S.
Parr et al. (2011), however, reported
no differences in QG distribution in
cattle fed for 174 and 197 d. Varying the timing of reimplant could
have affected QG distribution in
these studies. Similarly, Nichols et al.
(2014) reported no differences in YG
distribution.

Exp. 3—Performance
There were no differences (P ≥
0.36) in live or carcass-adjusted cattle
performance among the 3 implant
strategies (Table 3). As in Exp. 2, final live and carcass-adjusted BW did
not differ (P ≥ 0.64) among implant
programs. Similarly, deads-out carcass-adjusted ADG and G:F were not
different (P ≥ 0.36) between implant
strategy, agreeing with observations
from Exp. 2. These results are consistent with Samber et al. (1996) and
Nichols et al. (2014), who reported no
differences in DMI, ADG, G:F, and
final BW between implant strategies
of increased TBA and E2 dose. Additionally, there were no differences (P
≥ 0.15) in HCW or USDA marbling
score when comparing the 3 treatments (Table 3). The Rev-XS/200

treatment group had greater (P <
0.01) LM area, decreased (P ≤ 0.05)
12th-rib fat thickness, and calculated
YG compared with the Rev-200/200
and Rev-IS/200 treatments. Similar
to Exp. 2, the Rev-IS/200 and RevXS/200 treatments were used; however, reimplant occurred on the same
day on feed (d 115) in Exp. 3 but differed between Rev-IS/200 (d 120) and
Rev-XS/200 (d 140) in Exp. 2. This
delay in implanting between the RevIS/200 and Rev-XS/200 treatments
could explain why there were no differences observed for carcass characteristics in Exp. 2 but a difference in
Exp. 1. Samber et al. (1996) reported
no differences in HCW between aggressive implant strategies but noted
a decrease in 12th-rib fat thickness
and calculated YG as implant dosage
increased.
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The percentage of YG 1 carcasses
was greater (P = 0.03) for RevXS/200 compared with Rev-IS/200
carcasses. There was a decrease (P
= 0.01) in the percentage of YG 4
carcasses in Rev-XS/200 carcasses
compared with Rev-200/200 and RevIS/200 carcasses. This shift in YG
distribution is the result of differences
in LM area and 12th-rib fat thickness.
There were no differences (P ≥
0.28) in the percentage of cattle that
graded Choice or greater; however,
the Rev-200/200 and Rev-XS/200
treatments had an increase (P = 0.03)
in the percentage of carcasses that
graded USDA Select compared with
Rev-IS/200. Samber et al. (1996)
reported that there was a decrease in
the percentage of Choice and Prime
grading carcasses as implant dosage
was increased. Similarly, Nichols et al.
(2014) reported no differences in QG
distribution between steers implanted
with Rev-IS/S or Rev-XS. Differences
in carcass characteristics between
Exp. 2 and 3 could be due to differences in reimplant date, cattle weight,
BW, and cattle handling at reimplant
in addition to environmental factors
as similar differences between implant
strategies were noted by Parr et al.
(2011) and Nichols et al. (2014).

Animal Health
Morbidity differences (P < 0.05)
were detected with Rev-IH/200 having the least, Rev-200/200 being
intermediate, and Rev-H/200 having
the greatest (P = 0.05) percentage
of morbidity (Table 4). However,
there were no differences (P ≥ 0.12)
in mortality or rejected-percentage.
Rev-XS/200 had the lowest morbidity percentage, and Rev-XS/S had
the greatest (P = 0.02). However, as
noted in Exp. 1, there were no differences (P ≥ 0.26) in the mortality or
rejected-percentage. In Exp. 3 there
were no differences (P ≥ 0.60) in the
number of animals treated for illness,
mortalities, or removed animals. Munson et al. (2012) reported that there
were numerical differences in steer
morbidity and no differences in steer
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mortality when comparing an initial
to a delayed implant treatment similar to a lesser- and greater-dose initial
implant, which is in agreement with
the current steer studies. Additionally,
Gruber et al. (2011) reported no differences in morbidity between implant
treatments in both steers and heifers.
Whereas differences in morbidity in
Exp. 1 and 2 were detected and not in
Exp. 3, these data would suggest that
increased initial implant dosage does
not have an effect on animal health.

IMPLICATIONS
Economic incentives have led to use
of more aggressive implant strategies
to illicit a greater gain and efficiency
response. However, it appears the use
of aggressive implant strategies and
increased dosages may not be beneficial for daily gain and efficiency
of gain during the finishing phase
in steers and heifers. Use of aggressive implant strategies could decrease
carcass fatness and improve YG but
reduce QG in heifer and steer calves
when compared with a traditional implant strategy that uses a lesser-dose
initial implant followed by a greaterdose terminal implant.
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